Performance of high-dose omalizumab in chronic urticaria is predicted by initial improvement to standard dose
Publication date
2024-11
Authors
Simons, Juliette V.L.
Soegiharto, Reineke
Knulst, A C
van den Reek, Juul M.P.A.
Röckmann, Heike
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
cc_by_nc_nd
Abstract
Keywords
Immunology and Allergy
Citation
Simons, J V L, Soegiharto, R, Knulst, A C, van den Reek, J M P A & Röckmann, H 2024, 'Performance of high-dose omalizumab in chronic urticaria is predicted by initial improvement to standard dose', Journal of Allergy and Clinical Immunology: In Practice, vol. 12, no. 11, pp. 3163-3165.e2. https://doi.org/10.1016/j.jaip.2024.06.014